Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

September 21, 2022

Wearable Device for Continuous, Noninvasive Fluid Status Monitoring in Hemodialysis Patients (Alio)

Presentation TCT 2022

Wearable Device for Continuous, Noninvasive Fluid Status Monitoring in Hemodialysis Patients (Alio)

Presenter: David John Kuraguntla

September 17, 2022

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

August 23, 2022

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

High Lp(a) May Predict Risk of CV and Limb Events in PAD

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

July 18, 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

May 18, 2022

Fewer Lead-Related Complications With Subcutaneous ICD: ATLAS S-ICD

News Conference News HRS 2022

Fewer Lead-Related Complications With Subcutaneous ICD: ATLAS S-ICD

April 30, 2022

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

February 22, 2022

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

News Industry News

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

January 22, 2022

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

News Daily News

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Michael O'Riordan

January 12, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.